Evidence map›Paper›PMID 21628657›Full record

ArticleThe Journal of infectious diseases2011

An experimental mouse model to establish Tropheryma whipplei as a diarrheal agent.

Khatoun Al Moussawi, Nada Malou, Jean-Louis Mege, Didier Raoult, Benoit Desnues

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Pulmonary infection caused byTranslational pediatrics · 2026
    Article
  3. Human genetics of Whipple's disease.Current opinion in rheumatology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tropheryma whipplei: a common bacterium in rural Senegal.PLoS neglected tropical diseases · 2011
    Article
  9. Whipple disease research accelerates.The Journal of infectious diseases · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Khatoun Al MoussawiCentre National de Recherche Scientifique, Université de la Méditerranée, Marseille, France.
Nada Malou
Jean-Louis Mege
Didier Raoult
Benoit Desnues
Institut de Neurobiologie de la Méditerranée · FRUnité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tropheryma whipplei has long been considered as a rare bacterium causing a rare disease, Whipple's disease. However, recent advances now suggest that T. whipplei is a ubiquitous environmental bacterium that may cause gastroenteritis, commonly associated with viral pathogens. We developed an animal model to support this hypothesis. We found that orally given T. whipplei induced diarrhea in mice, without spreading into the intestines. Aggravating factors, such as damage to the intestinal mucosa, favored bacterial spreading. Indeed, bacterial presence was prolonged in stools of dextran sulfate-treated mice, and bacteria were detected in the colon. This resulted in an immune response, with T. whipplei-specific serum IgM and IgG and fecal IgA, as measured by newly introduced immuno-polymerase chain reaction technique. Our results confirm that T. whipplei is an agent causing gastroenteritis and suggest that existing mucosal damage may favor bacterial invasion of tissues.

Indexed as

Disease Models, AnimalAnimalsAntibodies, BacterialColonDiarrheaFecesFemaleGastroenteritisImmunoglobulin AImmunoglobulin GImmunoglobulin MMiceMice, Inbred C57BLRodent DiseasesTropherymaWhipple DiseaseAntibodies, BacterialImmunoglobulin AImmunoglobulin GImmunoglobulin M

Identifiers

PMID21628657
PMCPMC3307160
OpenAlexW2137417115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.